Article Information
History
- July 6, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Nina Ekström1,*,
- Anu Haveri1,
- Anna Solastie1,
- Camilla Virta1,
- Pamela Österlund1,
- Hanna Nohynek2,
- Tuomo Nieminen3,
- Lauri Ivaska4,
- Paula A. Tähtinen4,
- Johanna Lempainen4,5,6,
- Pinja Jalkanen7,
- Ilkka Julkunen5,7,
- Arto A. Palmu8 and
- Merit Melin1
- 1Expert Microbiology Unit, Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland
- 2Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland
- 3Data and Analytics Unit, Department of Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland
- 4Department of Pediatrics and Adolescent Medicine, Turku University Hospital, Turku, Finland
- 5Clinical Microbiology, Turku University Hospital, Turku, Finland
- 6Immunogenetics laboratory, Institute of Biomedicine, University of Turku, Turku, Finland
- 7Infection and Immunity, Institute of Biomedicine, University of Turku, Turku, Finland
- 8Interventions Unit, Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Tampere, Finland
- ↵*Corresponding author
Nina Ekström, Finnish Institute for Health and Welfare, POB 30, 00271 Helsinki, Finland, nina.ekstrom{at}thl.fi
Posted July 06, 2022.
Strong neutralizing antibody responses to SARS-CoV-2 variants following a single vaccine dose in subjects with previous SARS-CoV-2 infection
